- Drugs
- Monday, 04 May 2020
Pharmaceutics International Selected as A Winner of Two GH&P Awards
Pharmaceutics International, Inc. (Pii), a US-based Contract Development and Manufacturing Organization (CDMO) today announced it has won the 2020 CDMO Leadership Award and was named the Most Innovative Company in Dosage Solutions by Global Health & Pharma Magazine.
"We are honored to be recognized in these two categories. Pii has an extensive range of technologies, skilled personnel and Pharmaceutics Know-How™, to enable the rapid development and reliable production of high-quality sterile and oral dosage forms. It is extremely gratifying to have our innovation, accomplishments and commitment to partners and patients acknowledged," said Dr. Kurt R. Nielsen, Pii's President and CEO.
According to GH&P, "Biotechnology is a huge, varied and ever-growing industry. Operating and succeeding in such an environment which, in many ways, demands excellence at every turn is - it goes without saying - incredibly difficult, yet there are businesses that have learned to thrive under such conditions. To harness innovation and deliver results, driving the greater industry onwards." Jazmin Collins, GH&P Awards Coordinator, commented "Regardless of their size or location, we honor companies from across this vibrant and talented sector."
Related Industry Updates
Esteve acquires German proprietary, specialty, hospital-focused company Riemser and expands its presence in Europe
Jan 08, 2020
FDA Grants Avatrombopag Orphan Drug Designation for the Treatment of Chemotherapy-induced Thrombocytopenia
Dec 23, 2019
Sanofi says COVID-19 vaccine will be available globally at the same time
May 15, 2020
Lyophilization Services for Biopharmaceuticals Market is expected to reach US$ 3,586.55 million by 2028
May 23, 2023
Emerging nations represent an excellent opportunity for the pharmaceutical industry to develop anti-fungal drugs
Sep 24, 2019
Dry Eye Products Market 2031: Trends, Growth Drivers & Future Outlook
Nov 20, 2025
Clinical Trial Imaging Market is expected to reach US$ 2,480.32 million by 2028
May 23, 2023